Table 1.
Extract/Natural Product | Study Group and Duration of Treatment | Dosage | Comments | References |
---|---|---|---|---|
Ginger rhizome | Patients ≤ 50 years 8 weeks |
≥3 g per day | ↓ Systolic and diastolic blood pressure, possibly due to antioxidant potential | [43,44] |
Ginger rhizome | Patients | (0–2, 2–4 and 4–6 g/day) | ↓Hypertension by 8 and 13% | [48,49] |
Ginger rhizome | Patients | ≥2 g per day | ↓ TAG and LDL-C in blood | [51] |
Ginger extract | 120 patients | 30 mg of ginger extract in 2 capsules a day for 1 month | ↓ Pain ↑ Joint motion |
[32] |
Ginger extract with Echinacea extract | 15 patients with osteoarthritis; >60 years of age; men/women ratio: 2/13 | 25 mg ginger and 5 mg of Echinacea extract, 30 days | ↓ Pain ↓ Knee circumference |
[33] |
Ginger rhizome | 60 patients with postoperative sequelae; men/women ratio: 24/36 | 500 mg of powdered ginger rhizome; oral administration, every 6 h after surgery | ↓ Pain Similar effects to ibuprofen |
|
Ginger rhizome | 24 healthy overweight women 20–30 years of age | 3 g of powdered ginger a day; oral administration for 10 weeks with and without training | ↓ Systolic blood pressure ↓ Diastolic blood pressure in the group treated with ginger with no training |
[49] |
Ginger extract | 32 50-day-old male Sprague-Dawley rats | 250 mg/kg b.w. water extract, 3 times a week; oral gavage, 4 weeks | ↓TAG, TC and LDL; ↑HDL in combination with aerobic training ↑ LHD and AST biomarkers ↑ CK-MB, cTn-I and cTN-T in plasma |
[52] |
Ginger extract | 24 male albino Wistar rats (200–250 g) | 250 mg/kg b.w. of methanolic ginger extract daily for 3 weeks | ↓Plasma sugar levels ↓ Hyperglycemia ↓ Hyperinsulinemia |
[55] |
Ginger juice | Rats with alloxan-induced diabetes (150 mg/kg b.w.) | 4 mL/kg b.w. daily, oral administration for 6 weeks | ↓Plasma sugar levels ↑ HDL ↓ TC, TAG, LDL, creatinine, uric acid |
[54] |
Ginger extract | Rats with streptozotocin-induced diabetes | 200 mg/kg b.w. of water extract, 20 days | ↓ Hyperglycemia ↓ TC ↑ Cholesterol 7-alpha-hydroxylase activity ↓ Levels of liver and pancreas thiobarbituric-acid-reactive substances |
[11] |
6-Shogaol | Guinea pig | - | ↓ Sleep apnea ↑ Relaxation of blood vessels ↓ Blood pressure |
[50] |
Ginger extract | 7-week-old male mice [55] and male Sprague-Dawley rats [55] | 0.3–0.4% ginger extract added to the high-sugar and high-fat diet feed for 2 weeks [55] and 35 days [55] | ↓ Obesity by PPAR receptor regulation ↓ Body weight ↑Energy expenditure, heat production ↓ Hyperglycemia |
[55,56] |
Ginger extract | 24 male Sprague-Dawley rats | 20 and 50 mg/kg b.w. of 95% ethanol extract daily by oral gavage for 5 weeks together with fructose solution | ↑ Heat production ↓Fructose-overconsumption-induced adipose tissue insulin resistance in rats ↓ Cytokines |
[57] |
Ginger essential oils | Rats | 12 weeks | Treatment of nonalcoholic fatty liver disease → Modulation of the hepatic-SREBP-1c- and CYP2E1-mediated pathway ↓ Hyperlipidemia ↓TG, TC |
[58] |
Ginger extract | 40 5-week-old female BALB/c mice with induced colitis | p.o., 100, 300 and 500 mg/kg b.w. 21 days, once a day |
↓ Body weight ↓ Colon length ↓ Number of neutrophils and pro-inflammatory cytokines (IL-6 and TNF-α) |
[22] |
6-Gingerol | 40 I/R-induced male Sprague-Dawley rats | Oral gavage, 25 and 50 mg/kg b.w., 3 days before operation, once a day |
↓ IL-1β, IL-6 and TNF-α | [21] |
6-Shogaol | Improved translocation of Nrf2 factor ↑ OH-1 |
[40] | ||
6-Gingerol | 40 I/R-induced Male Sprague-Dawley rats | Oral gavage, 25 and 50 mg/kg b.w., 3 days before operation, once a day |
↓ Lipid peroxidation ↑ SOD, glutathione and peroxidase activity |
[21] |
Ginger extract with Lactobacillus acidophilus | 75 Wistar rats, 8–10 weeks old with DMH-induced inflammation | 50 mg/kg of ginger CO2 extract and 109 CFU of L. acidophilus; 1 month, once a day | ↓ MDA, TNF-α, COX-2, iNOS, c-Myc ↑ CAT, SOD levels |
[23] |
GEO | Mice with autoimmune encephalomyelitis (EAE) | 200 and 300 mg/kg | ↓ IL-12, TGF-β | [24] |
GEO | 48 male albino rats, 12 weeks old, with induced nephrotoxicity | Essential oil from ginger, 50 mg/kg b.w.; oral administration | ↓ Urea, creatinine and blood urea nitrogen ↑ Renoprotection ↑ Adenosine deaminase activity resulting in neuroprotective effect |
[25,26] |
6-Gingerol | Streptozotocin-induced (50mg/kg) 7-week-old male Wistar rats | 75 mg/kg/day oral administration |
↓ Acetylcholinesterase levels ↓ Pro-inflammatory cytokines Treatment of Alzheimer’s disease ↓ BWG%, ↓ GSH/GSSG |
[59] |